Please login to the form below
AIFA
This page shows the latest AIFA news and features for those working in and with pharma, biotech and healthcare.
Vertex strikes Italian reimbursement deal for Orkambi
AIFA gives the go-ahead for the cystic fibrosis treatment. Vertex has struck a market access deal in Italy for its cystic fibrosis treatment Orkambi (lumacaftor/ivacaftor). ... The reimbursement agreement with the Italian Medicines Agency (AIFA) will,
Latest news
-
EU starts investigation of Aspen's cancer drug pricing
Aspen's price rises were not acted on by the UK, but in Italy the drugmaker was fined after threatening the Agenzia Italiana del Farmaco (AIFA) that it would stop supplying
-
Italian pharma scandals prompts call for EU-wide pricing probe
Aspen was accused of effectively blackmailing the Italian regulatory agency AIFA in the case, threatening to interrupt supply of four essential cancer drugs - acquired from GlaxoSmithKline (GSK) - if it did not ... said AIFA in a statement.
-
Italy investigates Novartis vaccine after death toll reaches 13
Nevertheless, the Swiss company said it was taking the reports very seriously and was collaborating with AIFA during the investigation. ... Nine of the 13 Italian deaths have been in people aged over 80, according to AIFA, which reported that there was a
-
Italian pharma market set for continued downturn
GlobalData also highlighted the role of the Italian Medicines Agency (AIFA), which negotiates drug prices through a combination of internal and external referencing. ... If the AIFA and a manufacturer can't agree on a price for a particular drug it
-
Pan-European compliance
For example, Italy operates a negative clearance system which requires the submission to Italian Medicines Agency (AIFA) ten days prior to use. ... Italy requires notification to the Italian Medicines Agency (AIFA). Netherlands requires that if the
More from news
Approximately 3 fully matching, plus 7 partially matching documents found.
Latest Intelligence
-
Biologic or biosimilar: what are prescribers thinking?
They are considered likely to gain significant market share with endorsement from national bodies such as the UK’s NICE, HAS in France and Italy’s AIFA, as well as influential
-
Outcomes shape the new European payer networks
Of the two, Italy arguably retains more centralised control, with its regulatory body Agenzia Italiana Del Farmaco (AIFA) making national decisions over pricing and reimbursement levels for new drugs.
-
The true meaning of market access?
Italy: Decisions on reimbursement are made at central level by AIFA.
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Solaris Health looks at the gene therapy revolution
and the Italian Medicines Agency, known as AIFA, struck a deal with the manufacturer, GSK, so that if the treatment doesn’t work, they have negotiated a money back guarantee.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- A new era for UK-Japanese scientific research relations
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- FDA issues innovative proposal to increase nonprescription drug access
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- My journey advancing the science in pulmonary hypertension
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
PMHub
Healthcare Media Europe – HME Ltd
HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
